Pfizer beat earnings expectations and raised its full-year sales and profit outlook
Pfizer raised full-year revenue guidance by $1.5 billion at the midpoint, to a range of $62.0 billion to $64.0 billion
We haven't written up this one. Quartz has the full story — the link below goes straight to it.